Co-Authors
This is a "connection" page, showing publications co-authored by JEFFREY KIM and BRYAN CANNON.
Connection Strength
1.985
-
Magnetic versus manual catheter navigation for ablation of free wall accessory pathways in children. Circ Arrhythm Electrophysiol. 2012 Aug 01; 5(4):804-8.
Score: 0.416
-
Isolated junctional tachycardia in a patient with pheochromocytoma: an unusual presentation of an uncommon disease. Pediatr Cardiol. 2008 Sep; 29(5):986-8.
Score: 0.304
-
Maintenance of AV synchrony in a small child utilizing two pacemakers and the triggered VVT mode: triggered pacing in small children. Pacing Clin Electrophysiol. 2007 Nov; 30(11):1404-7.
Score: 0.303
-
Limited utility of exercise stress tests in the evaluation of children with chest pain. Congenit Heart Dis. 2012 Sep-Oct; 7(5):455-9.
Score: 0.105
-
Impact of the American Heart Association scientific statement on screening electrocardiograms and stimulant medications. Arch Pediatr Adolesc Med. 2011 Feb; 165(2):166-70.
Score: 0.095
-
Use of a cardioselective beta-blocker for pediatric patients with prolonged QT syndrome. Pediatr Cardiol. 2011 Jan; 32(1):63-6.
Score: 0.093
-
Electrocardiographic abnormalities and arrhythmias are strongly associated with the development of cardiomyopathy in muscular dystrophy. Heart Rhythm. 2010 Oct; 7(10):1484-8.
Score: 0.091
-
Cross-stimulation: a rare complication of chronic epicardial leads. J Cardiovasc Electrophysiol. 2009 Sep; 20(9):1065-7.
Score: 0.083
-
Ventricular function and long-term pacing in children with congenital complete atrioventricular block. J Cardiovasc Electrophysiol. 2007 Apr; 18(4):373-7.
Score: 0.073
-
Radio-frequency catheter ablation of accessory pathway mediated tachycardia in a child after orthotopic heart transplantation. J Heart Lung Transplant. 2005 Sep; 24(9):1444.
Score: 0.065
-
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Cardiol Young. 2021 Nov; 31(11):1738-1769.
Score: 0.049
-
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: executive summary. Cardiol Young. 2021 Nov; 31(11):1717-1737.
Score: 0.049
-
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary. Heart Rhythm. 2021 11; 18(11):1925-1950.
Score: 0.049
-
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients. Heart Rhythm. 2021 11; 18(11):1888-1924.
Score: 0.049
-
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). JACC Clin Electrophysiol. 2021 11; 7(11):1437-1472.
Score: 0.049
-
Wolff-Parkinson-White syndrome: De novo variants and evidence for mutational burden in genes associated with atrial fibrillation. Am J Med Genet A. 2020 06; 182(6):1387-1399.
Score: 0.045
-
High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr Cardiol. 2011 Oct; 32(7):896-903.
Score: 0.024
-
Frequency of cardiac death in children with idiopathic dilated cardiomyopathy. Am J Cardiol. 2009 Dec 01; 104(11):1574-7.
Score: 0.022
-
Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol. 2009 Jul 14; 54(3):250-4.
Score: 0.021